Scholar Rock says its drug preserved lean mass in patients taking Zepound

statnews.com/2025/06/18/scholar-rock-apitegromab-lean-mass-preservation-obesity-drugs

Scholar Rock said Wednesday that its investigational therapy helped preserve lean mass among patients taking a powerful weight loss drug, as concerns grow that patients taking new obesity treatments may be losing too much muscle.
A Phase 2 trial tested the drug, apitegromab, in…

This story appeared on statnews.com, 2025-06-18 16:23:06.704000.
The Entire Business World on a Single Page. Free to Use →